Isradipine

CAS 75695-93-1 6 current records 2 historicalSmall Molecule

Who holds supplier records for Isradipine? 6 organisations hold a current record for Isradipine: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Spain (1), India (1) and Sweden (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Isradipine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/isradipine

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Isradipine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Spain1India1Sweden1Country not recorded for 3
  • QUIMICA SINTETICA SA
    Active DMF 17367 · latest filing May 2004
    SpainCEP Company GMP cert on record
  • CHEMOSWED AB
    Active DMF 19376 · latest filing Apr 2006
  • SOLARA ACTIVE PHARMA SCIENCES LTD
    Active DMF 16369 · latest filing Jan 2003
    India Company GMP cert on record
  • STERLING WISCONSIN LLC
    Active DMF 16812 · latest filing Aug 2003
  • YANGZHOU PHARMACEUTICAL CO LTD
    Active DMF 17384 · latest filing May 2004
  • MAGLE CHEMOSWED AB
    Valid CEP holder (EDQM); not necessarily the manufacturer
    SwedenCEP
Need Isradipine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Isradipine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
QUIMICA SINTETICA S.A. Alcala De HenaresES
CEP 2024-072 - Rev 00
Isradipine, Micronised, non-micronised
Sept 2025Inspected Apr 2025
Spain
MAGLE CHEMOSWED AB MalmöSE
R1-CEP 2007-303 - Rev 03
Isradipine
Feb 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Isradipine are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Overview

Isradipine is a calcium channel blocker used to treat hypertension by relaxing blood vessels, allowing blood to flow more easily. It is also used in some cases of angina to improve blood flow and reduce pain.

Chemical identity

IUPAC name
3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
Canonical SMILES
CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
InChIKey
HMJIYCCIJYRONP-UHFFFAOYSA-N
Synonyms
DynaCirc API, dynacirc, nsc-759892, pn 200-110, pn-200-110

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Dihydropyridine Calcium Channel Blocker
Mechanism of action
Calcium Channel Antagonists
Chemical structure
Dihydropyridines

Therapeutic areas

Cardiovascular DiseasesHypertension

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Isradipine?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Isradipine: QUIMICA SINTETICA SA (Spain), CHEMOSWED AB, SOLARA ACTIVE PHARMA SCIENCES LTD (India), STERLING WISCONSIN LLC, YANGZHOU PHARMACEUTICAL CO LTD and MAGLE CHEMOSWED AB (Sweden). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Isradipine Drug Master Files are active?

QUIMICA SINTETICA SA (DMF 17367), CHEMOSWED AB (DMF 19376), SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 16369), STERLING WISCONSIN LLC (DMF 16812) and YANGZHOU PHARMACEUTICAL CO LTD (DMF 17384). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Isradipine records mean?

2 organisations have only inactive Type II DMFs for Isradipine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Isradipine have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Isradipine on the EDQM register, including QUIMICA SINTETICA S.A. Alcala De Henares (ES) and MAGLE CHEMOSWED AB Malmö (SE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Isradipine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Isradipine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.